Analyst Group Comment on Stenocare:s Approval for a new Medical Cannabis CBD100 oil - Analyst Group

On December 17th, STENOCARE announced that the company has received approval for a new product in Denmark, CBD100, which has a high concentration of CBD active ingredients (100 mg/ml). This makes STENOCARE the only supplier to offer a CBD100 oil product in Denmark.

Länk till analysen i sin helhet: https://analystgroup.se/kommentarer/comment-on-stenocares-approval-for-a-new-medical-cannabis-cbd100-oil/